How the Opioid-Induced Constipation Treatment Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Opioid-Induced Constipation Treatment Market?
The increased use of opioids for cancer and non-cancer pain is expected to boost the opioid-induced constipation treatment market. Opioids are essential for pain relief but can lead to constipation, necessitating supportive treatments. These treatments improve comfort and adherence to pain management. According to the Government of Canada in May 2021, up to 8.3 million Canadians may suffer from chronic pain by 2025, rising to 9.0 million by 2030. Therefore, the market for opioid-induced constipation treatment is growing with the broader use of opioids.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15881&type=smp
How Has the Opioid-Induced Constipation Treatment Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The opioid-induced constipation treatment market showed strong growth, climbing from $1.78 billion in 2024 to $1.9 billion in 2025 at a CAGR of 7.0%. This growth stems from a larger elderly population, personalized treatments, effective drugs, more opioid use, and increasing digestive health issues.
The opioid-induced constipation treatment market is projected to grow to $2.47 billion in 2029, with a CAGR of 6.7%. Growth is driven by accelerated drug approval, rising opioid analgesic use, increased investment in R&D, and the development of biologics. Trends include patient education, the emergence of targeted therapies, non-pharmacological interventions, biotechnology innovations, and increased investment.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15881
What Are the Most Significant Market Trends Transforming theOpioid-Induced Constipation Treatment Market?
Major companies in the opioid-induced constipation treatment market are engaging in strategic partnerships to drive innovation. In November 2022, Kyowa Kirin Co. Ltd partnered with Grünenthal GmbH to expand access to pain management treatments, including for opioid-induced constipation.
What Are the Top Market Players Propelling the Growth of theOpioid-Induced Constipation Treatment Industry?
Major companies operating in the opioid-induced constipation treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International GmbH., Shionogi & Co. Ltd., Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Mundipharma International Limited, Lantheus Holdings Inc., Indivior plc, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals SA, Nektar Therapeutics, RedHill Biopharma Ltd., Theravance Biopharma Inc., Cumberland Pharmaceuticals Inc., Valinor Pharma LLC
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Opioid-Induced Constipation Treatment Market Are Driving Growth and Industry Transformations?
The opioid-induced constipation treatment market covered in this report is segmented –
1) By Drug Class: Laxatives, Peripherally Acting ?-opioid Receptor Antagonists, Serotonin Receptor Agonists, Prostaglandin
2) By Type: Oral, Parenteral
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Subsegments:
1) By Laxatives: Osmotic Laxatives, Stimulant Laxatives, Bulk-Forming Laxatives
2) By Peripherally Acting ?-Opioid Receptor Antagonists: Naloxegol, Methylnaltrexone, Alvimopan
3) By Serotonin Receptor Agonists: Prucalopride, Tegaserod
4) By Prostaglandin: Lubiprostone
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15881&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Opioid-Induced Constipation Treatment Market?# Market?
North America was the largest region in the opioid-induced constipation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioid-induced constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Opioid-Induced Constipation Treatment Market 2025, By The Business Research Company:
Merkel Cell Carcinoma Treatment Global Market Report 2024
Basal Cell Carcinoma Treatment Global Market Report 2024
Encephalitis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/encephalitis-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
